There is a challenge related to prostate and many other cancers that cancer cells form resistance to treatments as the disease progresses. However, these resistance mechanisms are not yet fully ...
Researchers have determined that type II innate lymphoid cells (ILC2s), a type of immune cell, can change its characteristics and functions after a cancer patient receives stem cells from a donor, ...
PSA as a predictor of small cell transformation in prostatic adenocarcinoma: A SEER 2000-2021 study.
Global burden of prostate cancer in 38 OECD countries and its trend from 1990-2021: An Insight from the Global Burden of Disease study 2021. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
“Allogeneic transplants can be very effective, and potentially lifesaving, but not all immune cells given to a recipient are reproduced from donor cells,” said Jonathan Serody, MD. “Innate type 2 ...
The image shows prostate cancer cells in which KLF4 (red) and the CD44 protein (green) on the cell membrane are stained. There is a challenge related to prostate and many other cancers that cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results